Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study
NRG Oncology
Charles N Landen; Ronald J Buckanovich; Michael W Sill; Robert S Mannel; Joan L Walker; Paul A DiSilvestro; Cara A Mathews; David G Mutch; Marcia L Hernandez; Lainie P Martin; Erin Bishop; Sarah E Gill; Mary E Gordinier; Robert A Burger; Carol Aghajanian; Joyce F Liu; Kathleen N Moore; Michael A Bookman
Clinical Trials Development Division, NRG Oncology Statistical and Data Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY.